--- a
+++ b/clusters/9knumclustersv2/clust_1003.txt
@@ -0,0 +1,21 @@
+Patients with a known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Subjects with a known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Known intolerance to study drug (or any of the excipients) and/or known hypersensitivity to rapamycins (eg, sirolimus, everolimus, temsirolimus) or any of the excipients
+Patients with a known hypersensitivity to everolimus or other rapamycins (e.g. sirolimus, temsirolimus)
+Known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients
+History of hypersensitivity to sirolimus, temsirolimus, everolimus
+Patients with a known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Patients with a known hypersensitivity to everolimus or other rapamycins (e.g., sirolimus, temsirolimus) or to its excipients
+Patients with a known hypersensitivity to RAD(everolimus) or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Patients with a known hypersensitivity to everolimus or other rapamycins (e.g., sirolimus, temsirolimus) or to its excipients
+Patients must not have any known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Known hypersensitivity to RAD or other rapamycins (sirolimus, temsirolimus, deforolimus)
+Patients with a known hypersensitivity to everolimus or other rapamycins (e.g., sirolimus, temsirolimus) or to its excipients
+Patients with known hypersensitivity to rapamycins
+Patients with a known hypersensitivity to everolimus (RAD) or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Patients with a known hypersensitivity to everolimus or other rapamycins (e.g., sirolimus, temsirolimus) or to its excipients
+Patients with a known hypersensitivity to RAD (everolimus) or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Patients with a known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients, or to bortezomib, boron, or mannitol
+Patients with a known hypersensitivity to everolimus or other rapamycins (sirolimus, temsirolimus) or to its excipients
+Known hypersensitivity to thalidomide or everolimus (including other rapamycins, sirolimus and temsirolimus)
+Patients with a known hypersensitivity to RAD (everolimus) or other rapamycins (e.g., sirolimus, temsirolimus) or to its excipients